TuHURA Biosciences, Inc./NV filed a Form D with the Securities and Exchange Commission on 2025-06-13.
TuHURA Biosciences, Inc./NV filed a Form D notice of an exempt securities offering with the SEC on June 13, 2025. The filing reports $2.23M sold. Its industry group is Biotechnology. It names James Bianco (Executive Officer, Director), James Manuso (Director), George Ng (Director) (SEC Form D, June 13, 2025).
Is this your company?
Sell to companies like TuHURA Biosciences, Inc./NV? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-06-13 · the record
Pitching, partnering or investing alongside them? See who really runs and owns TuHURA Biosciences, Inc./NV.
Free to see. No signup.
More on the people and the money behind TuHURA Biosciences, Inc./NV, from the filings we hold.
Brookline Capital Markets, a division of Arcadia Securities, LLC received sales compensation on this raise and on 6 other raises we hold, nearest in date first:
Paulson Investment Company, LLC received sales compensation on this raise and on 6 other raises we hold, nearest in date first:
Biotechnology raises by companies based in Florida, filed in June 2025, largest first.
Get an email when TuHURA Biosciences, Inc./NV files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when TuHURA Biosciences, Inc./NV raises, hires or launches. No email unless you switch it on.
Watch TuHURA Biosciences, Inc./NV →Get the full cited report on TuHURA Biosciences, Inc./NV
What the filing shows about TuHURA Biosciences, Inc./NV
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on TuHURA Biosciences, Inc./NV: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives TuHURA Biosciences, Inc./NV's address as 10500 University Dr., Suite 110, Tampa, FL 33612.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on TuHURA Biosciences, Inc./NV See pricing
TuHURA Biosciences, Inc./NV is a registered filer with the SEC (CIK 1498382) and has filed since 2025-06-13. 2 filings are on record, the latest on 2025-11-10.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
TuHURA Biosciences, Inc./NV's Form D of 2025-06-13 names James Bianco, James Manuso, George Ng and 4 more as its officers, directors or promoters.
Its new offerings report $3.73M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 769 filings in Biotechnology, totalled by week.
James Bianco is named as Executive Officer and Director on the Form D that TuHURA Biosciences, Inc./NV filed with the SEC on 13 June 2025, one of 7 people that filing names.
James Manuso is named as Director on the Form D that TuHURA Biosciences, Inc./NV filed with the SEC on 13 June 2025, one of 7 people that filing names.
George Ng is named as Director on the Form D that TuHURA Biosciences, Inc./NV filed with the SEC on 13 June 2025, one of 7 people that filing names.
Alan List is named as Director on the Form D that TuHURA Biosciences, Inc./NV filed with the SEC on 13 June 2025, one of 7 people that filing names.
Robert Hoffman is named as Director on the Form D that TuHURA Biosciences, Inc./NV filed with the SEC on 13 June 2025, one of 7 people that filing names.
Craig Tendler is named as Director on the Form D that TuHURA Biosciences, Inc./NV filed with the SEC on 13 June 2025, one of 7 people that filing names.
Dan Dearborn is named as Executive Officer on the Form D that TuHURA Biosciences, Inc./NV filed with the SEC on 13 June 2025, one of 7 people that filing names.
7 people named on the filing — 2 holding an executive role and 5 as directors only.
Named as of the 2025-06-13 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about TuHURA Biosciences, Inc./NV
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on TuHURA Biosciences, Inc./NV: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on TuHURA Biosciences, Inc./NV covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist TuHURA Biosciences, Inc./NVYou get an alert in MentionFox the next time this company shows up.
If you're behind TuHURA Biosciences, Inc./NV: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for TuHURA Biosciences, Inc./NV. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Orlando and Tampa
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/tuhura-biosciences-inc-nv-form-d-25000002